Safety of biologics in severe asthmatic patients with SARS-CoV-2 infection: A prospective study.

Sara Manti,Alessandro Giallongo,Giulia Pecora,Giuseppe F Parisi,Maria Papale,Enza Mulè,Donatella Aloisio,Novella Rotolo,Salvatore Leonardi

Pediatric pulmonology（2023）

引用 1|浏览13

暂无评分

摘要

We showed that the scheduled dose of the biologic therapy can be administered safely on time in patients with SARS-CoV-2 infection, as the treatment did not result in adverse events or outcomes.

查看译文

关键词

COVID-19,asthma,dupilumab,mepolizumab,monoclonal antibodies,omalizumab,safety

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要